Previous Article | Next Article 
Journal of Clinical Microbiology, March 2003, p. 1322-1325, Vol. 41, No. 3
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.3.1322-1325.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Prospective Clinical Evaluation of the Serologic Tuberculous Glycolipid Test in Combination with the Nucleic Acid Amplification Test
Ryoji Maekura,1* Hiroaki Kohno,2 Atsushi Hirotani,1 Yoshinari Okuda,1 Masami Ito,1 Takeshi Ogura,1 and Ikuya Yano3
Toneyama National Hospital, Osaka,1
Fuji Research Laboratories, Kyowa Medex Co., Ltd., Shizuoka ,2
Department of Bacteriology, Osaka City University Medical School, Osaka, Japan3
Received 22 March 2002/
Returned for modification 12 October 2002/
Accepted 18 December 2002
We have conducted a prospective controlled multicenter study to evaluate differences in the levels of clinical utility of the tuberculous glycolipid (TBGL) serodiagnostic test and the nucleic acid amplification test in patients with smear-negative active pulmonary tuberculosis (TB). The TBGL test and the PCR test were individually not so useful for the rapid diagnosis of smear-negative active pulmonary TB. However, clinical utility was considerably improved by using the TBGL test and the PCR test in combination, especially in patients with smear-negative and culture-negative active pulmonary TB and in patients with minimally advanced lesions.
* Corresponding author. Mailing address: Toneyama National Hospital, 5-1-1, Toneyama Toyonaka-city, Osaka 560-0045, Japan. Phone: 81-6-6853-2001. Fax: 81-6-6850-1750. E-mail:
maekurar{at}toneyama.hosp.go.jp.
Journal of Clinical Microbiology, March 2003, p. 1322-1325, Vol. 41, No. 3
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.3.1322-1325.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fujita, Y., Doi, T., Maekura, R., Ito, M., Yano, I.
(2006). Differences in serological responses to specific glycopeptidolipid-core and common lipid antigens in patients with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium avium complex. J Med Microbiol
55: 189-199
[Abstract]
[Full Text]
-
Fujita, Y., Doi, T., Sato, K., Yano, I.
(2005). Diverse humoral immune responses and changes in IgG antibody levels against mycobacterial lipid antigens in active tuberculosis. Microbiology
151: 2065-2074
[Abstract]
[Full Text]
-
Kitada, S., Maekura, R., Toyoshima, N., Naka, T., Fujiwara, N., Kobayashi, M., Yano, I., Ito, M., Kobayashi, K.
(2005). Use of Glycopeptidolipid Core Antigen for Serodiagnosis of Mycobacterium avium Complex Pulmonary Disease in Immunocompetent Patients. CVI
12: 44-51
[Abstract]
[Full Text]
-
Banerjee, S., Nandyala, A., Podili, R., Katoch, V. M., Murthy, K. J. R., Hasnain, S. E.
(2004). Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients. Proc. Natl. Acad. Sci. USA
101: 12652-12657
[Abstract]
[Full Text]
-
Okuda, Y., Maekura, R., Hirotani, A., Kitada, S., Yoshimura, K., Hiraga, T., Yamamoto, Y., Itou, M., Ogura, T., Ogihara, T.
(2004). Rapid Serodiagnosis of Active Pulmonary Mycobacterium tuberculosis by Analysis of Results from Multiple Antigen-Specific Tests. J. Clin. Microbiol.
42: 1136-1141
[Abstract]
[Full Text]